Filter your results
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanomaJournal of Clinical Investigation, 2017, 127 (6), pp.2310 - 2325. ⟨10.1172/JCI91291⟩
Journal articles
hal-01788013v1
|
||
|
Molecular Heterogeneity Between Paired Primary and Metastatic Lesions from Clear Cell Renal Cell CarcinomaEuropean Urology Open Science, 2022, 40, pp.54-57. ⟨10.1016/j.euros.2022.04.004⟩
Journal articles
inserm-03772186v1
|
||
|
MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell CarcinomaCancers, 2021, 13 (7), pp.1554. ⟨10.3390/cancers13071554⟩
Journal articles
hal-03209171v1
|
||
|
Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With SunitinibClinical Genitourinary Cancer, 2019, 17 (2), pp.e235-e246. ⟨10.1016/j.clgc.2018.11.002⟩
Journal articles
inserm-02532766v1
|